Home NDC 71209-004
Acyclovir
Product NDC 71209-004
11-digit product format 712090004
Labeler code 71209
Product ID 71209-004_9b62ab17-f153-447b-b4d6-78dead35afde
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Acyclovir
Dosage form CAPSULE
Route ORAL
Labeler Cadila Pharmaceuticals Limited
Application ANDA201445
Marketing category ANDA
Marketing start 2015-12-29
Substance ACYCLOVIR
Active strength 200 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Acyclovir
Listing expiration 2027-12-31
Active Ingredients# Ingredient, Strength table Ingredient Strength ACYCLOVIR 200 mg/1
Harmonized Identifiers# Field, Values table Field Values Unii X4HES1O11F Rxcui 197310
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 71209-004-05 Acyclovir 100 in 1 BOTTLE CAPSULE 100 7 71209-004-10 Acyclovir 500 in 1 BOTTLE CAPSULE 500 7
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 71209-004 ACYCLOVIR CAPSULE [CADILA PHARMACEUTICALS LIMITED] 6 Current NDC, Legacy NDC, 2 package rows 20230306_dbaf4bf5-57e3-4770-a9b2-d47649e54c1b.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 71209-004-05 71209000405 100 CAPSULE in 1 BOTTLE (71209-004-05) 100 capsule 2018-11-20 0000-00-00 No No Current 71209-004-10 71209000410 500 CAPSULE in 1 BOTTLE (71209-004-10) 500 capsule 2018-11-20 0000-00-00 No No Current